Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using endoscopic vacuum therapy for treating defects in the upper gastrointestinal tract

Official title: Endoscopic Vacuum Therapy for Anastomotic Leakage After Upper Gastrointestinal Surgery / Endoscopic Vacuum Therapy for Esophageal Perforation: A Multicenter Retrospective Cohort Study

Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT05606822 · Data updated 2026-11-12

This study is testing if endoscopic vacuum therapy can effectively treat serious problems in the upper digestive tract, like leaks and perforations, to help improve patient care.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Academic / other
Locations1 site (Amsterdam)
StatusRecruiting
StartedOctober 1, 2021
Main results expectedOctober 1, 2030
Study endsOctober 1, 2030
Registry record updatedJuly 23, 2024
Trial IDNCT05606822 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who have undergone EVT for anastomotic leakage following esophago-gastric surgery.

Probably not a fit

Patients who do not provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness and best practices of endoscopic vacuum therapy (EVT) for patients with transmural defects in the upper gastrointestinal tract, such as anastomotic leaks and esophageal perforations. The study will collect both retrospective and prospective data to determine the success rates of EVT and identify optimal indications and techniques for its application. Participants will provide informed consent to allow for comprehensive data collection regarding their treatment outcomes and characteristics. The findings could help refine treatment protocols for these serious conditions.

Why it matters

Potential benefit: If successful, this study could improve treatment strategies for patients with upper GI tract defects, potentially reducing complications and improving recovery outcomes.

How similar studies have gone: While EVT is a relatively novel approach for treating upper GI tract defects, previous studies have shown promising results in similar contexts, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Treated with EVT for anastomotic leakage after esophago-gastric surgery
* Signed informed consent form
* 18 years or older

Exclusion Criteria:

* No signed informed consent

Where it's running

  • Amsterdam University Medical Centers, location VUmc
    Amsterdam, Netherlands
    Recruiting

Study contacts

  • Principal investigator: Roos Pouw, MD, PhD — Amsterdam University Medical Center, location VU
  • Study coordinator: Roos Pouw, MD, PhD
  • Email: r.e.pouw@amsterdamumc.nl
  • Phone: +3120 4444444

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.